跳至主要内容
临床试验/NCT04427657
NCT04427657已完成不适用

Adipose Microfragmented Autologous Tissue for the Treatment of Knee Osteoarthritis

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio4 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2018年11月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
78
试验地点
4
主要终点
Symptomatic and functional evaluation at 6 months by comparison of the KOOS score recorded between the two groups

研究概览

简要总结

Lipogems system consist in the use of a monouse kit for liposuction, processing and administration of adipose tissue. The use of the final product (microfragmented adipose tissue,not expanded) shoud promote the natural joint homeostasis, associated with a clinical improvement

详细描述

The Objectiveof the study is to analyse the therapeutic role of microfragmented autologous tissue for the treatment of the knee osteoarthritis (OA).

Main purpose: Symptomatic and functional evaluation at 6 months by comparison of the Knee Injury and Osteoarthritis Outcome Score(KOOS) recorded between two groups (6±1 months) undergoing arthroscopic debridement ± injection of autologous microfragmented lipoaspirate tissue (Lipogems®).

Secondary Purposes: Evaluation of possible radiological changes pre-operative and after 6±1 months by means of MagneticResonanceImage analysis. Symptomatic and functional evaluation at 6±1 months by means of VisualAnalogueScale, KneeSocietyScore, Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC). Reduction of anti-inflammatory drugs (pre-intervention versus 6±1 months). Evaluation "quality-adjusted life years" (QUALY) in relation to the questionnaire SatisfactioForm-12 (pre-intervention vs 6±1 months). Check for any adverse effects directly related to the use of micro-fragmented adipose tissue. Changes in serum levels of biomarkers related to OA (CollagenType II C-Telopeptide (CTX-II), collagen type III N-propeptide (PIIINP)) will be evaluated (pre-intervention vs 6±1 months).

The study is an interventional, prospective, randomized, controlled trial. Controls: n = 39 patients with knee osteoarthritis undergoing arthroscopic debridement. Cases: n = 39 patients with knee osteoarthritis undergoing arthroscopic debridement surgery + intrarticular injection of autologous microfragmented lipoaspirate tissue (Lipogems®).

Surgical technique: patient in supine position. A double contemporary operating fields is made under sedation. During arthroscopic debridement is made an injection of local anesthetic at the dermal level with a subcutaneous infiltration of Klein solution. The plastic surgeon wait for about 5 minutes for vasoconstriction and then start with liposuction of about 60 ml of adipose tissue. Then lipoaspirate was processed with Lipogems® technique that consist in a mechanical fragmentation, physiological washing and filter passage of the lipoaspirate. A volume of 8-9 ml of microfragmented adipose tissue was injected intra-articulary after arthroscopic debridement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with knee osteoarthritis grade III e IV Kellgren-Lawrence,
  • age between 45 and 75,
  • pain ≥ 6 VAS scale,
  • no ligamentous instability,axial deviation less than 10°
  • BMI between 18 and 30,
  • International Normalized Ratio (INR) < 1.5

排除标准

  • previous traumatic lesion (tibial fracture, osteothomy) of the knee
  • osteonecrosis
  • meniscal surgery in the previous 6 weeks
  • chemiotherapy, radioteherapy
  • alchoolism, psichiatric disease,drug addiction
  • coagulation disorders
  • pregnancy

结局指标

主要结局

Symptomatic and functional evaluation at 6 months by comparison of the KOOS score recorded between the two groups

时间窗: 6 month

Symptomatic and functional evaluation at 6 months by comparison of the KOOS score recorded between two groups (6±1 months) undergoing arthroscopic debridement ± injection of autologous microfragmented lipoaspirate tissue (Lipogems®).

次要结局

  • Radiological changes at 6 month recorded between the two groups(6 month)
  • Functional changes at 6 month recorded between the two groups(6 month)
  • Serum changes at 6 month recorded between the two groups(6 month)

研究者

发起方
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验